Key details
Collaborators
Peking University Third Hospital, Xuanwu Hospital, Beijing
Enrollment target
~1 participants
Primary completion
October 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years – 80 Years
Last updated February 2025